Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -42.69 | 45.01 |
| PEG Ratio (TTM) | 0.23 | 8.30 |
| P/S Ratio (TTM) | 1.98 | 15.81 |
| P/B Ratio (TTM) | 5.07 | 16.62 |
| P/FCF Ratio (TTM) | 16.49 | 48.05 |
| Price to 5YR AVG Earnings Ratio | -10.03 | 17.51 |
| Price to 5YR AVG FCF Ratio | -93.84 | 56.15 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -3.51% | 12.28% |
| ROE (TTM) | -12.14% | 58.13% |
| Net Profit Margin (TTM) | -4.64% | 24.15% |
| ROIC 5YR AVG | -103.17% | -13.31% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -20.69% | -2.77% | 23.02% |
| Revenue | 3.33% | 19.90% | 12.64% |
| Net Income | -21.89% | -12.94% | 17.30% |
| Cash Flow | 610.00% | 377.15% | 254.34% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.86 | 1.55 |
| Quick Ratio (TTM) | 0.86 | 1.53 |
| D/E Ratio (TTM) | 0.62 | 0.92 |
| Interest Coverage (TTM) | -25.53 | 55.44 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 0.05 | 11.34 |
| LTL to 5YR AVG FCF | -10.40 | 5.26 |
| Shares Outstanding Growth 5YR AVG | 4.90% | 2.08% |